Rating Change
Wedbush reiterated its Outperform rating on STAAR Surgical Company (NASDAQ:STAA) on August 13, 2026.
reiterateNASDAQ:STAA
Wedbush Reiterates Outperform Rating on STAAR Surgical Company (STAA)
Wedbush reiterated its Outperform rating on STAAR Surgical Company (NASDAQ:STAA) on August 13, 2026.
At publication ·
What changed
STAAR Surgical Company (NASDAQ:STAA) · reiterate
- Firm
- Wedbush
- Rating
- Outperform to Outperform
- Price at event
- $25.33
- Market capitalization
- $1.2B
At a glance
Key takeaways
- Wedbush reiterated an Outperform rating on STAAR Surgical Company (STAA) on August 13, 2026, with the stock trading at $25.33 and a market capitalization of $1.2 billion.
Market Context
STAAR Surgical Company operates in the Healthcare sector. The stock currently trades at $25.33 with a market capitalization of $1.2B. The stock has declined 11.1% over the past 52 weeks.
Analyst coverage from Wedbush provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for STAAR Surgical Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for STAAR Surgical Company
Among the 10 most recent ratings: 6 Buy, 2 Hold, 2 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | UBS | Sell | N/A |
| Aug 13, 2026 | Wedbush | Outperform | N/A |
| Aug 04, 2026 | Wedbush | Outperform | N/A |
| Jul 28, 2026 | UBS | Sell | N/A |
| Jul 22, 2026 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View STAA Stock Page
Frequently Asked Questions
What does the Outperform rating mean for STAA?
A rating of Outperform from Wedbush reflects the analyst's outlook on STAAR Surgical Company (NASDAQ:STAA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the STAA forecast page.